We need more, https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research

1. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 2/11
DEA WANTS MORE RESEARCH ON CANNABIS AND MUSHROOMS
The DEA Wants You to Grow Way More
Cannabis and Mushrooms in 2022 for
Research
The DEA needs way more marijuana and mushrooms in 2022 to do research!
Posted by:
Laurel Leaf, today at 12:00am
 Edit Article (https://cannabis.net/mycannabis/c-blog-entry/update/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research)
 Article List (https://cannabis.net/mycannabis/c-blog)

2. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 3/11
DEA Wants Way More Cannabis & Psychedelics for
Research In 2022
The interest in marijuana globally isn't rescinding anytime soon. This has birthed confidence in the hearts of
marijuana enthusiasts that it may lead to more research and possibly federal legalization. Well, such hopes for
legalization steam from news like this: the DEA wanting more cannabis and psychedelics for research in the
coming year 2022.
The DEA calling for a mass increase in production
The Drug Enforcement Administration has made an official call for a dramatic increase in research-based
psychedelics and cannabis production for 2022. In a report by Marijuana Moment, the Federal agency will
declare its interest in a notice scheduled for publication on Monday that has become the topic of interest
within the cannabis industry.
The DEA has already increased its 2021 quota for psilocybin and cannabis in September 2021 but is now calling
for an even larger quantity of research-grade cannabis with a broader array of psychedelics for production in
2022.
A plan to double the number of cannabis extracts, psilocin and psilocybin, quadruple mescaline, and quintuple
DMT is in the works, and the most outstanding is MDMA. The DEA has proposed a massive 6,300% increase in
drug production from 50 grams in 2021 to 3,200 grams in 2022. There will be more research into the
therapeutic potentials of the drug.
While LSD will have a 1.150% increase which is up to 500 grams of powerful psychedelic, cannabis will get a
60% boost under this new DEA proposal, up to 3.2 million grams in 2022 from its initial 2 million grams in
2020.
The reason for the increase in research-based cannabis and psychedelics

3. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 4/11
In its Register Notice (https://www.federalregister.gov/documents/2021/10/18/2021-22624/proposed-
aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment-of), the DEA
mentioned that it has been getting and approving new applications for organizations to "Grow, synthesize,
extract and manufacture dosage forms containing schedule 1 hallucinogenic substances for clinical trial
purposes."
The DEA also maintains that it supports 'Regulated" research with schedule 1 monitored substances which it
has proven through its proposed increase in production in 2022 compared to what was obtainable in 2021.
The agency added that it was diligently working to process and approve cannabis manufacturers' applications
because currently, there is only one farm at the University of Mississippi that allows for the plant's cultivation
for research purposes.
The increase in clinical trial applications from the DEA is as follows:
3.4 increase in Methylendioxymethamphetamine (MDMA)
5-Methoxy-N-N-Dimethyltryptamine
Dimethyltryptamine
Lysergic acid diethylamide (LSD)
Marihuana
Marihuana Extract
Mescaline
Psilocybin
Psilocyn
All Tetrahydrocannabinols
These increments will support manufacturing activities related to the heightened level of research and clinical
trials with the schedule 1 controlled substances.
A breakdown of the exact numbers for the 2021 and 2022 quotas:
Substance 2021 figures Proposed 2022 figures
MDA 55 200
5-MeO-DMT 35 550
DMT 50 250

4. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 5/11
Mescaline 25 100
LSD 40 500
MDMA 50 3,200
Psilocyn 1.000 2.000
Psilocybin 1,500 3,000
All Tetrahydrocannabinol 1,000 2,000
Marijuana Extract 500,000 1,000,000
Marijuana 2,000,000 3.,200,000
The role of the public, researchers and experts
After the notice is published on Monday, the agency will have a 30-day comment timeline that allows people to
make comments about the new quotas. It is also interesting to note that these changes are happening
because of the public's interest in marijuana.
If the people are not keen on researching cannabis, then there will be no need to increase the quotas set in
2021. The DEA agrees that it cannot ignore the rising "Scientific and public" interest in cannabis and
psychedelics, leading to more clinical trials. These clinical trials all show the therapeutic potential of cannabis
which will be suitable for medicine.

5. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 6/11
The Director of the National Institute on Drug Abuse, Nora Volkov, asserts that she was encouraged by the
agency's proposed rise in the production quota. She also maintained that studies have repeatedly shown that
the advantages of psychedelics could make more people experiment with psilocybin.
Experts, researchers, and advocates for these fungi are frustrated by the strict rules which place the natural
gifts as a schedule 1 substance. They believe that given the fact that these substances have medical value for
some conditions, they shouldn't be categorized as 'Dangerous."
In August, a federal appellate court dismissed a petition to make the DEA reevaluate cannabis scheduling
under its Controlled Substance Act. But after the ruling, a judge gave a concurring opinion that the agency may
be compelled to reconsider a change in its policy. These changes may be necessary because the therapeutic
value of marijuana has been misinterpreted.
In a separate petition, the attorney general's office of the Washington State and its lawyers representing
cancer patients have urged a federal appeal panel to enable a policy change with the DEA. The policy change is
meant to allow people experiencing the end of life medical care to gain access to psilocybin under federal and
state "Right to Try" laws. These moves from researchers and experts are made to show the DEA that it has
been fighting a lost battle against cannabis for the longest time. It is now time to give nature's gift to us a
chance to positively impact Americans' lives.
Although there is much excitement about all that will happen in 2022, one can only imagine the progress we
would have made if we had started much earlier. Hopefully, this move also compels other states that haven't
legalized cannabis to reconsider their decisions and take a forward-thinking stance.
Bottom Line
When a federal agency like the DEA starts increasing its quota on any substance or shows such keen interest in
a substance, it tells a lot about it. Yes, cannabis is still largely illegal at the federal level, and this should be a
good reason for the DEA to avoid all marijuana-related conversations.
Yet, here we are, reading exciting news about the possibility of increasing the amount of cannabis produced
for research purposes. This shows that in 2022, so much more will happen in the cannabis industry, and the
DEA is already positioning itself for that experience. The greater the marijuana research, the higher the
possibility of more marijuana-based products manufactured for commercial use. What a time to be a cannabis
enthusiast and watch the industry blossom even further in 2022!!
What did you think?
Keep reading... click here
(https://cannabis.net/blog)
0 0 0 0 0 0

6. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 7/11
Leave a Comment:
Submit
What are your thoughts?
OPINION (HTTPS://CANNABIS.NET/BLOG/OPINION) VIDEOS (HTTPS://CANNABIS.NET/BLOG/VIDEOS)
DABS (HTTPS://CANNABIS.NET/BLOG/DABS) HISTORY (HTTPS://CANNABIS.NET/BLOG/HISTORY)
SPORTS (HTTPS://CANNABIS.NET/BLOG/SPORTS) MEDICAL (HTTPS://CANNABIS.NET/BLOG/MEDICAL)
INTERVIEW (HTTPS://CANNABIS.NET/BLOG/INTERVIEW) SMOKE (HTTPS://CANNABIS.NET/BLOG/SMOKE)
RECIPES (HTTPS://CANNABIS.NET/BLOG/RECIPES) VAPING (HTTPS://CANNABIS.NET/BLOG/VAPING)
LOCATIONS (HTTPS://CANNABIS.NET/BLOG/LOCATIONS)
PERSONAL STORY (HTTPS://CANNABIS.NET/BLOG/PERSONAL-STORY) FUNNY (HTTPS://CANNABIS.NET/BLOG/FUNNY)
STRAINS (HTTPS://CANNABIS.NET/BLOG/STRAINS) TECHNOLOGY (HTTPS://CANNABIS.NET/BLOG/TECHNOLOGY)
EVENTS (HTTPS://CANNABIS.NET/BLOG/EVENTS) SEXY (HTTPS://CANNABIS.NET/BLOG/SEXY)
VOTE (HTTPS://CANNABIS.NET/BLOG/VOTE) NEWS (HTTPS://CANNABIS.NET/BLOG/NEWS)
HOW TO (HTTPS://CANNABIS.NET/BLOG/HOW-TO) B2B (HTTPS://CANNABIS.NET/BLOG/B2B)
CATEGORIES

7. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 8/11
(https://cannabis.net/blog/funny/what-to-do-on-mothers-day-1700-miles-away)
FEATURED
FUNNY
What To Do On Mother's Day 1,700 Miles Away
As I awoke this morning from another island night out, I wondered what would make this last day a delight and make my Mom proud. In all honesty, I
was really looking for a cure for this mild vacation hangover from the multiple margaritas, pain killers, La

8. 11/8/21, 10:23 AM The DEA Wants You to Grow Way More Cannabis and Mushrooms in 2022 for Research
https://cannabis.net/blog/news/the-dea-wants-you-to-grow-way-more-cannabis-and-mushrooms-in-2022-for-research 9/11
(https://cannabis.net/blog/medical/medical-cannabis-for-juvenile-myoclonic-epilepsy)
MEDICAL
Medical Cannabis for Juvenile Myoclonic Epilepsy
There are many studies that show over the years that CBD specifically works effectively for seizures. The studies were not easy to fulfill due to the
strict regulations, but studies done on those struggling from JME show great promise. The endocannabinoid system plays a significant role in the
ictal (period of seizure) control and neuronal balance. Cannabis has the ability to reduce seizure frequencies.